American Marconi Wireless News - CBD Life Sciences Inc. (CBDL) Lands Major Order from Bronx Dispensary "Smoking Scholars," Signaling Explosive Growth Ahead for CBD-Infused Drinks Division

SCOTTSDALE, AZ, AZ / ACCESS Newswire / October 14, 2025 / CBD Life Sciences Inc. (OTC:CBDL), parent company of CBD Vault, proudly announces a major order from Smoking Scholars Dispensary, located at 784 Allerton Avenue, Bronx, NY 10467, marking a powerful expansion milestone in the company's rapidly growing beverage division.

Smoking Scholars, a premier dispensary serving thousands of customers across the Bronx and greater New York City area, has officially placed a large-scale order of CBDL's top-performing drinks, including:

• 16oz 50mg CBD Lemonade

• 16oz 25mg CBD Raspberry Lemonade

• 16oz 25mg CBD Lavender Lemonade

• CBD-Infused Water

These top-tier beverages have quickly become fan favorites for their refreshing taste, balanced CBD infusion, and consistent quality. Their arrival at Smoking Scholars represents a major win for CBDL's East Coast expansion strategy, opening the door to recurring orders, brand visibility, and strategic retail placement in one of the most dynamic cannabis and wellness markets in the country.

The CBD beverage market continues to show unprecedented growth, projected to exceed $4.2 billion by 2030 with a compound annual growth rate (CAGR) of over 25%. With consumer interest surging in functional wellness drinks, CBDL's infused beverage line is strategically positioned to capture a significant share of this booming sector.

"This is an extremely exciting development for the company," said a spokesperson for CBD Life Sciences Inc. "The Bronx represents one of the most competitive and lucrative retail markets in the U.S. - and getting our beverages onto Smoking Scholars' shelves proves that CBDL is no longer just participating in the CBD industry, we're leading a movement. The momentum behind our CBD drinks has been phenomenal, and we're already in discussions with several additional dispensaries eager to join the wave."

This major order also reflects the direct results of CBDL's participation at the NECANN Cannabis Conference, where the company showcased its expanding product portfolio to hundreds of retail buyers, distributors, and dispensary owners. The event has already produced multiple partnership leads and letters of intent, with Smoking Scholars being one of several new accounts developed through these networking efforts.

The partnership is expected to generate substantial recurring revenue through bulk beverage orders, with projections indicating six-figure monthly sales potential as the company onboards additional dispensary partners. Beyond this milestone, CBDL has ongoing negotiations with retailers and dispensaries across New Jersey and Pennsylvania, creating a growing regional pipeline of future sales and distribution opportunities.

As the functional beverage space continues to gain mainstream traction, CBDL's infused drink line stands out for its clean ingredients, exceptional flavor, and reliable dosage consistency - all qualities that drive strong customer retention and retailer reorders.

About CBD Life Sciences Inc. (CBDL)
CBD Life Sciences Inc. is a publicly traded company (OTC: CBDL) under its retail subsidiary CBD Vault, specializing in premium hemp-derived wellness products, including topicals, tinctures, edibles, and infused beverages. Through innovation, strategic partnerships, and a rapidly expanding retail network, the company continues to deliver consistent growth and long-term shareholder value.

Follow our social media for the latest updates!
X: https://www.x.com/CBDL_StockOTC
Instagram: https://www.instagram.com/cbd.vault
Website: https://www.thecbdvault.com
IR Contact: [email protected]

Stay Connected & Be the First to Try Our New Functional Mushroom Products!

Mushroom Madness Instagram: https://www.instagram.com/mushroom.madnessaz
Mushroom Madness Website: https://www.mushroommadness.shop

Forward-Looking Statements
Except for the historical information contained herein, the matters discussed in this press release are forward-looking statements. Actual results may differ materially from those described in forward-looking statements and are subject to risks and uncertainties. See CBD Life Sciences, Inc's, Inc.'s filings with OTC Markets, which may identify specific factors that may cause actual results or events to differ materially from those described in the forward-looking statements.

Safe Harbor Statement
This release includes forward-looking statements, which are based on certain assumptions and reflects management's current expectations. These forward-looking statements are subject to a number of risks and uncertainties that could cause actual results or events to differ materially from current expectations. Some of these factors include: general global economic conditions; general industry and market conditions, sector changes and growth rates; uncertainty as to whether our strategies and business plans will yield the expected benefits; increasing competition; availability and cost of capital; the ability to identify and develop and achieve commercial success; the level of expenditures necessary to maintain and improve the quality of services; changes in the economy; changes in laws and regulations, including codes and standards, intellectual property rights, and tax matters; or other matters not anticipated; our ability to secure and maintain strategic relationships and distribution agreements. The Company disclaims any intention or obligation to update or revise any forward-looking ability to secure and maintain strategic relationships and distribution agreements. The Company disclaims any intention or obligation to update or revise any forward-looking statements.

Contact Information
Lisa Nelson
CEO
[email protected]
4802091720

SOURCE: CBD Life Sciences, Inc.

View the original press release on ACCESS Newswire

M.Thompson--AMWN